Heart Attacks Look Different in Women

By Dr. Georgine Nanos, MD, MPH | Board-Certified Family Physician, Kind Health Group

She was 52. She went to the ER with jaw pain, nausea, and exhaustion. She told them it had been building for two days. She was discharged with a diagnosis of anxiety and sent home with a prescription.

She came back 36 hours later with a heart attack in progress.

Her story is not unusual. It's the version I hear over and over — in my own practice, in the cardiology literature, in conversations with women who describe the year before their cardiac event as one long string of symptoms that were attributed to stress, aging, perimenopause, or their mental state.

Heart disease is the leading cause of death in women. It kills more women each year than all forms of cancer combined. And it is systematically underdetected — in emergency rooms, in annual physicals, and in the minds of women themselves — because nearly everything we were taught to recognize about cardiac disease was based on research conducted almost entirely on men.

The Real Problem: A Research Gap That's Still Killing Women

The Cardiac Blind Spot is not a metaphor. It has a documented history.

The landmark clinical trials that established our understanding of heart disease — the Framingham Heart Study, the major statin trials, the early angiography research — enrolled predominantly or exclusively male subjects. The "classic" heart attack presentation taught in medical schools — crushing chest pain radiating down the left arm — is the male presentation. It is both accurate and incomplete.

Women do experience chest pain. But they are significantly more likely than men to present with atypical symptoms: jaw pain, neck or back pain, nausea, profound fatigue, shortness of breath without chest pain, indigestion that doesn't resolve. They are also more likely to experience a MINOCA event — Myocardial Infarction with Non-Obstructive Coronary Arteries — a type of heart attack that doesn't show standard blockages on angiography and was, for decades, read as "normal" and sent home.

A 2018 study published in the European Heart Journal found that women who presented with heart attacks were significantly less likely than men to receive timely treatment — even after controlling for symptom severity. The gap wasn't biology. It was recognition failure.

The standard annual cholesterol panel — total cholesterol, LDL, HDL, triglycerides — was designed and validated on male populations. It is an inadequate predictor of cardiovascular risk in women. Studies published in JAMA and the American Heart Association's journals have consistently shown that advanced lipid testing, particularly ApoB (apolipoprotein B), is a superior predictor of cardiovascular events in women — and is virtually never ordered in standard primary care.

What I See in Practice

The patients I worry about most for cardiac risk are often not the ones with the highest LDL on their annual lab panel. They're the women who have multiple modest risk signals that no one has ever considered together: slightly elevated ApoB, elevated lipoprotein(a), a C-reactive protein that's been creeping up, a resting heart rate that's increased over the last two years, and a blood pressure that's "fine" at 128/82 — which is technically not hypertension but is meaningfully elevated compared to where it was a decade ago.

Each individual value might not trigger a conversation. In aggregate, they tell a story about cardiovascular inflammation and arterial stress that needs proactive intervention now, not after an event.

Menopause is a cardiac risk transition point that most physicians never address explicitly with their patients. Estrogen has direct protective effects on the cardiovascular system — it supports endothelial function, reduces LDL oxidation, and maintains arterial flexibility. When estrogen drops at menopause, cardiovascular risk rises. The rate of cardiovascular disease in women accelerates sharply in the decade after menopause and within 10 to 15 years matches and then exceeds men's lifetime risk.

This is not a reason to panic. It is a reason to evaluate, establish baselines, and intervene with the tools available — including hormone therapy, where appropriate, as part of a comprehensive cardiovascular risk picture.

In North County San Diego, I see a lot of women who are doing everything "right" by conventional standards and still have risk accumulating underneath. The right approach is to measure it correctly, not to assume that a normal LDL and a negative family history means you're safe.

What Comprehensive Cardiovascular Assessment Actually Looks Like

Standard annual physical cardiovascular evaluation: total cholesterol, LDL, HDL, triglycerides. Blood pressure. Resting heart rate. Done.

That is the bare minimum and, for women, it consistently misses the most predictive signals.

Comprehensive cardiovascular evaluation includes:

Standard annual physical cardiovascular evaluation: total cholesterol, LDL, HDL, triglycerides. Blood pressure. Resting heart rate. Done.

That is the bare minimum and, for women, it consistently misses the most predictive signals.

Comprehensive cardiovascular evaluation includes:

ApoB (Apolipoprotein B): The most important cardiovascular biomarker you've likely never been offered. ApoB measures the total number of atherogenic (plaque-forming) particles in the blood — a stronger predictor of cardiovascular events than LDL-C in both sexes but especially in women with metabolic changes from perimenopause. A normal LDL with a high ApoB means you have a large number of small, dense LDL particles that don't register as a high LDL but are highly atherogenic.

Lipoprotein(a) — Lp(a): A genetically determined cardiovascular risk factor that is independent of diet, exercise, and other lifestyle factors. Elevated Lp(a) significantly increases risk of heart attack and stroke, particularly in women. It is not affected by statins. It needs to be measured once in every adult's lifetime as a baseline — and almost never is.

High-sensitivity C-reactive protein (hsCRP): A marker of systemic inflammation with strong predictive value for cardiovascular events, independent of cholesterol levels. The JUPITER trial demonstrated that treating patients with normal LDL but elevated hsCRP with statins significantly reduced cardiovascular events.

Coronary artery calcium (CAC) score: A low-radiation CT scan that quantifies actual calcified plaque in the coronary arteries. It is the most direct available measurement of atherosclerotic burden and provides powerful guidance on treatment decisions. It is particularly useful in women who don't clearly fall into standard risk categories.

Continuous blood pressure monitoring and resting heart rate trends: Not one reading in a clinical setting, but pattern assessment over time.

At Kind Health Group, we integrate these assessments into a comprehensive cardiovascular risk picture — and we do it proactively, before there's an event to diagnose.

What You Can Do Right Now

First: request ApoB and Lp(a) on your next labs. Ask specifically by name. These are standard tests covered by most insurance with physician order. If your doctor doesn't know why you're asking for them, that's information.

Second: learn the female presentation of cardiac symptoms. Jaw pain, neck or back pain, profound unusual fatigue, nausea, and shortness of breath are all documented presentations of cardiac events in women. If you experience these — especially in combination, or if they're new — do not let them be dismissed as anxiety or GI issues without a cardiac workup.

Third: understand that menopause is a cardiovascular event horizon. If you are within 5 years before or after menopause, your cardiovascular risk profile is changing and it deserves attention now, not at your next annual physical.

If you're in Encinitas, Del Mar, Carlsbad, or anywhere in North County San Diego and you want a physician who evaluates your cardiovascular health the way the research says it should be evaluated in women, that's what we do at Kind Health Group. kindhealthgroup.com.

Frequently Asked Questions

What are the symptoms of a heart attack in women?

Women are more likely than men to experience atypical heart attack symptoms: jaw, neck, or back pain; nausea; unusual fatigue; shortness of breath without chest pain; and indigestion that does not resolve. Chest pain or pressure does occur in women but is less consistently the primary symptom. These differences have contributed to women being undertreated and underdiagnosed in emergency settings.

Is heart disease the leading cause of death in women?

Yes. Heart disease is the leading cause of death in women in the United States, killing more women each year than all forms of cancer combined. Despite this, most women significantly underestimate their personal risk, and cardiovascular disease is consistently under-screened for in routine women's health care. Risk accelerates significantly in the decade after menopause.

What is ApoB and why is it important for women?

ApoB (apolipoprotein B) measures the total number of atherogenic particles in the blood — a stronger predictor of cardiovascular events than standard LDL cholesterol, particularly in women. After menopause, women frequently develop a lipid pattern characterized by normal LDL but elevated ApoB, indicating high particle count that traditional testing misses. ApoB is a standard lab test, covered by most insurance, and almost never ordered in routine primary care.

Does menopause increase heart disease risk?

Yes, significantly. Estrogen has protective effects on the cardiovascular system — it supports arterial flexibility, reduces LDL oxidation, and maintains endothelial function. When estrogen declines at menopause, these protections diminish. Cardiovascular disease rates in women increase sharply in the decade following menopause. This is a well-documented transition that warrants proactive cardiovascular assessment, and in appropriate patients, may be part of the rationale for hormone therapy.

What is lipoprotein(a) and should I get tested?

Lipoprotein(a), or Lp(a), is a genetically determined lipid particle that significantly increases cardiovascular risk independent of diet, exercise, or other lifestyle factors. Elevated Lp(a) is one of the most common inherited cardiovascular risk factors and is not reduced by statins. The American Heart Association recommends that all adults have Lp(a) measured at least once as a baseline. Most people have never had it tested.

How do I find a women's heart health doctor in San Diego?

Look for a physician with specific training in preventive medicine and women's cardiovascular health who orders comprehensive lipid panels — including ApoB, Lp(a), and hsCRP — not just a standard cholesterol check. Kind Health Group in Encinitas provides comprehensive cardiovascular risk evaluation for women, including advanced lipid testing, coronary calcium score referral, and hormone-informed risk assessment as part of concierge primary care. kindhealthgroup.com.

Look for a physician with specific training in preventive medicine and women's cardiovascular health who orders comprehensive lipid panels, including ApoB, Lp(a), and hsCRP  not just a standard cholesterol check. Kind Health Group in Encinitas provides comprehensive cardiovascular risk evaluation for women, including advanced lipid testing, coronary calcium score referral, and hormone-informed risk assessment as part of concierge primary care. kindhealthgroup.com.

Listen to The Kind Revolution Podcast — an entire episode dedicated to women's heart disease and what the system misses:

The #1 Killer of Women That Nobody Warned You About: Dr. Kharazi on Heart Disease and Myths — Cardiologist Dr. Kharazi joins Dr. Nanos to break down why women's heart disease is underdiagnosed, undertreated, and how the risk picture changes at menopause.

Wellness Theater vs. Real Medicine: A Doctor's Honest Take on Longevity Trends — Dr. Nanos on separating what the evidence actually supports from what the longevity industry sells — including cardiovascular risk markers and what to demand from your physician.

Also available on Apple Podcasts, Amazon Music, and YouTube. Search "The Kind Revolution."